Skip to main content
. 2021 Sep 16;47:102138. doi: 10.1016/j.redox.2021.102138

Table 1.

Demographic information for healthy controls and schizophrenia group (*; p<0.05).

Variable Healthy Controls (HC, N =10) Schizophrenia Group (SCZ, N=10) Test Statistics
Age/years 35.4 ± 12.3 40.9 ± 14.7 χ2= 0.46, p = 0.49
Sex/Male 10 (50%) 10 (50%) χ2= 0.20, p = 1
Race χ2= 0.28, p = 1
 African American 7 (70%) 7 (70%)
 Caucasian 2 (20%) 3 (30%)
 Mixed 1 (10%)
Smoker 3 (30%) 4 (40%) χ2= 0.95, p = 0.62
Clinical Assessment (Symptoms)
 *BPRS Total Score 19.6 ± 1.8 33.2 ± 5.3 χ2= 12.59, p = 3.9 × 10−4
 *SANS Total Score 1.0 ± 2.8 25.7 ± 9.2 χ2= 15.26, p = 9.36 × 10−5
 *HAMD 0.67 ± 1.4 8.8 ± 5.8 χ2= 11.61, p = 6.57 × 10−4
 *CGIS 1.0 ± 0.0 4.5 ± 0.8 χ2= 16.59, p = 4.63 × 10−5
 *RBANS Total Score 86.4 ± 15.1 71.0 ± 16.0 χ2= 4.66, p = 0.031
 Perceived Stress Scale 11.2 ± 9.7 14.5 ± 5.2 χ2= 0.57, p = 0.45
Physiological Measurement
 Systolic Blood Pressure (mmHg) 122.7 ± 21.7 117.7 ± 13.1 χ2= 0.036, p = 0.85
 *Diastolic Blood Pressure (mmHg) 67.2 ± 10.8 74.9 ± 5.2 χ2= 4.18, p = 0.041
 Pulse (bpm) 73 ± 14.4 83.9 ± 12.9 χ2= 1.56, p = 0.21